Found: 12
Select item for more details and to access through your institution.
HER2 Splice Site Mutation c.1899‐1G>A as the Potential Acquired Resistance to Trastuzumab in a Patient with HER2‐Positive Gastric Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 717, doi. 10.1002/onco.13799
- By:
- Publication type:
- Article
Metastatic Low‐Grade Sarcoma with CARS‐ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive Genomic Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 4, p. e524, doi. 10.1002/onco.13543
- By:
- Publication type:
- Article
New clinical trial design in precision medicine: discovery, development and direction.
- Published in:
- Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01760-0
- By:
- Publication type:
- Article
New clinical trial design in precision medicine: discovery, development and direction.
- Published in:
- Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01760-0
- By:
- Publication type:
- Article
Response to Pyrotinib in a Chinese Patient with Bone-Metastatic Scrotal Paget's Disease Harboring Triple Uncommon HER2 Mutation: A Case Report.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 6289, doi. 10.2147/OTT.S244814
- By:
- Publication type:
- Article
MTSS1 inhibits metastatic potential and induces G2/M phase cell cycle arrest in gastric cancer.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 5143, doi. 10.2147/OTT.S203165
- By:
- Publication type:
- Article
The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature review.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 4739, doi. 10.2147/OTT.S167346
- By:
- Publication type:
- Article
Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8<sup>+</sup>T cells.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 6, p. 1297, doi. 10.1007/s13402-022-00718-0
- By:
- Publication type:
- Article
Adenosquamous carcinoma of the bile duct: a population-based study.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 439, doi. 10.2147/CMAR.S144850
- By:
- Publication type:
- Article
Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50996-5
- By:
- Publication type:
- Article
Pan‐cancer efficacy and safety of anlotinib plus PD‐1 inhibitor in refractory solid tumor: A single‐arm, open‐label, phase II trial.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 4, p. 815, doi. 10.1002/ijc.34546
- By:
- Publication type:
- Article